InsidersTradesSigma
Track the POD stock price and the full directors' dealings record of the company, a listed issuer based in Australia. Shares are quoted on the AU market, under the oversight of ASX. Operating in the Healthcare & Pharma sector, POD has recorded 3 reports. Market capitalisation: €39.7m. The latest transaction was reported on 6 July 2026 (Mixed). The full history is accessible without an account.
3
Insider Decl.
n/a
Thresholds
€214,250
2 ops.
Buy Volume
n/a
n/a
Sell Volume
28Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,974 of 28,822 companies
30.9
score / 100
Value17
Quality45
FCF yld-9.7%
Earn yld-7.1%
EV/EBITDA·
ROE-5.6%
Gross mgn72%
Net mgn-0.1%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 July 2026
About POD
POD is a company operating in the health and pharmaceutical sector. It is listed on the XASX market.
